• Small-interfering RNA (siRNA) transfections were carried out in 6-well plates using 3μl of Lipofectamine 2000 (Life Technologies) and 40pmol of siRNA duplex per well. (biotech-angels.com)
  • Hydroxyurea belongs to the group of cancer-fighting medications known as antineoplastics , and specifically to the group of antineoplastics known as antimetabolites . (medbroadcast.com)
  • The recommended dose of hydroxyurea varies according to the specific condition being treated, the response to therapy, the other medications used, whether radiation is being used at the same time, the stage of condition, and the body weight of the recipient. (medbroadcast.com)
  • Antiretroviral medications may interfere with manufacturing of apheresed cells. (medscape.com)
  • While continuous glucose monitors (CGMs) can provide real-time data and alerts to help people with diabetes make informed decisions about their health, certain common medications can interfere with a device's accuracy and effectiveness. (glucosemonitors.net)
  • Fortunately, only a small number of continuous glucose monitor users take medications like hydroxyurea. (glucosemonitors.net)
  • Treatment options vary depending on underlying cause but typically involve lifestyle modifications such as quitting smoking if applicable combined with medications designed to reduce production of red cells in bone marrow (such hydroxyurea) or reduce absorption from intestines (such phlebotomy). (circadianbluelight.com)
  • The healthcare system can promote tailored strategies to reduce barriers and increase TCD screening and hydroxyurea use among children with sickle cell anemia. (cdc.gov)
  • Even though sensitivities to acetaminophen have been reduced, the Dexcom G6 CGM system still shows a problem when used with a drug called hydroxyurea , which is used for cancer treatment and sickle cell anemia. (glucosemonitors.net)
  • Factors influencing response were AML (vs. MDS), marrow blast count, pretreatment, transfusion dependency, concomitant medication with hydroxyurea, and valproic acid (VPA) serum level. (biomedcentral.com)
  • Hydroxyurea fights cancer by preventing the growth of cancer cells, which eventually results in their destruction. (medbroadcast.com)
  • When treating these types of cancers, hydroxyurea is usually used at the same time as radiation therapy, as these two methods work together to kill cancer cells more effectively. (medbroadcast.com)
  • As well as interfering with the genetic material DNA of cancer cells, hydroxyurea can interfere with some of your normal cells. (medbroadcast.com)
  • Hydroxyurea is used to treat cancer of the white blood cells called chronic myeloid leukemia (CML). (pharmika.co.in)
  • Hydroxyurea interferes with the growth of cancer cells, which are eventually destroyed by the body. (pharmika.co.in)
  • Hydroxyurea selectively inhibits ribonucleoside diphosphate reductase, an enzyme required to convert ribonucleoside diphosphates into deoxyribonucleoside diphosphates, thereby preventing cells from leaving the G1/S phase of the cell cycle. (blogspot.com)
  • This agent also exhibits radiosensitizing activity by maintaining cells in the radiation-sensitive G1 phase and interfering with DNA repair. (blogspot.com)
  • Ichthyosis vulgaris is a type of ichthyosis, a group of related skin conditions that interfere with the skin's ability to shed dead skin cells, causing extremely dry, thick skin. (medicalnewstoday.com)
  • Generic Efudex interferes with the growth of skin cells. (curecancer.ru)
  • The increased production of blood cells interferes with blood flow. (homeremedylifestyle.com)
  • It works by interfering with the growth of genetic material (DNA and RNA) of the cancer cells. (healthcaresurety.com)
  • Topoisomerase inhibitors block cancer cells from dividing and spreading by interfering with enzymes called topoisomerases. (healthline.com)
  • Hydroxyurea and transfusion therapy are strongly recommended for many individuals with SCD. (nih.gov)
  • A recommendation of moderate strength suggests offering treatment with hydroxyurea without regard to the presence of symptoms for infants, children, and adolescents. (nih.gov)
  • In addition, high hemoglobin levels can interfere with normal oxygen delivery throughout the body resulting in symptoms such as fatigue and shortness of breath due to decreased tissue perfusion. (circadianbluelight.com)
  • The exact mechanism of its action is unknown, it is supposed that it is cell cycle specific for the S phase of cell division, it interfere with synthesis of DNA, with no effect on synthesis of RNA or protein. (apoteket.to)
  • It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in. (targetmol.com)
  • Despite these recognised benefits, long-standing concerns regarding the risks of mutagenic and potentially carcinogenic drug exposure have hampered efforts for broad hydroxyurea use in SCA, although these are based largely on outdated experimental models and treatment experiences with myeloproliferative neoplasms. (cdc.gov)
  • Since hydroxyurea therapy for SCA carries minimal carcinogenic risks, the current drug labelling should be modified accordingly, and prescribing practices should be broadened to allow better access and increased utilisation of this highly effective drug. (cdc.gov)
  • Hydroxyurea therapy is strongly recommended for adults with 3 or more severe vasoocclusive crises during any 12-month period, with SCD pain or chronic anemia interfering with daily activities, or with severe or recurrent episodes of acute chest syndrome. (nih.gov)
  • Hydroxyurea therapy, which reduces the occurrence of several complications, including severe acute pain episodes and acute chest syndrome. (cdc.gov)
  • Hydroxyurea is used alone or in conjunction with other antitumor agents or radiation therapy to treat neoplastic diseases. (nih.gov)
  • Monitor blood counts at least once a week during hydroxyurea therapy. (nih.gov)
  • Use of experimental drug therapy for MF or any other standard drug used for MF (eg, danazol, hydroxyurea) with the exception of ruxolitinib, within 3 months of starting study drug, and/or lack of recovery from all toxicities from previous therapy (except ruxolitinib) to Grade 1 or better. (go.jp)
  • If receiving concurrent SCD-directed therapy (e.g., hydroxyurea, L-glutamine, crizanlizumab, or voxelotor), the patient must have been on a stable dose, except for weight-based titration, with good adherence by the investigator's assessment for a minimum of 3 months prior to study enrollment (Day 1). (who.int)
  • Hydroxyurea (hydroxycarbamide) is approved for treating both children and adults with sickle cell anaemia (SCA). (cdc.gov)
  • Increasing data indicate that hydroxyurea has a substantial effect on reducing mortality in both adults and children-perhaps the most compelling reason for advocating the drug's widespread use. (cdc.gov)
  • If radiation is also being used, hydroxyurea dosing should start at least 7 days before the start of radiation and continue throughout and after treatment, unless there are extreme side effects. (medbroadcast.com)
  • Consequently, there is a defect in recruitment of BLM to chromatin in response to ionising radiation-induced DSBs and to hydroxyurea-induced stalled and collapsed replication forks. (biomedcentral.com)
  • Chemotherapeutic strategies have used a variety of drugs and hormonal agents that interfere with the basic machinery of the cell. (nature.com)
  • Hydroxyurea has proven clinical efficacy for SCA - treatment significantly reduces disease manifestations and prolongs survival. (cdc.gov)
  • In this review, we describe the concept of genotoxicity and its laboratory measurements, summarise hydroxyurea-associated data from both preclinical and clinical studies, and discuss carcinogenic potential. (cdc.gov)
  • This review describes current considerations in the use of hydroxyurea for the management of sickle cell disease in the context of clinical severity. (cdc.gov)
  • So interfering with these factors might skirt the edge of excessive toxicity. (michaelsimm.de)
  • While rare, in some people with ichthyosis vulgaris, scaling interferes with the sweat glands causing either excessive sweating ( hyperhidrosis ) or an inability to sweat. (medicalnewstoday.com)
  • or interfere with interpretation of study data. (go.jp)
  • Live Vaccinations: Avoid live vaccine use in a patient taking hydroxyurea capsules. (nih.gov)
  • Active ingredient of this drug is hydroxyurea. (apoteket.to)
  • Active alcohol or drug addiction that would interfere with the ability to comply with the study requirements. (go.jp)
  • If your doctor thinks it is needed, you may also receive hydroxyurea to control your white blood cell count while you are on study. (survivornet.com)